Learning about Neurosurgery and Neurology

Learning about Neurosurgery and Neurology Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von Learning about Neurosurgery and Neurology, Medizin und Gesundheit, Hamburg-Wandsbek.

NeuroOncoEduInfo

A learning platform for neurosurgery/neurology (focus on neurosurgery and research in neurosurgery)

Further websites:
https://payhip.com/neuroonkologieheilversuchde

https://www.neuroonkologie-heilversuch.de/

https://pubmed.ncbi.nlm.nih.gov/41355353/
05/02/2026

https://pubmed.ncbi.nlm.nih.gov/41355353/


Brain metastases (BrMs) may present with intralesional or intracranial hemorrhage (ICH), yet risk factors and outcomes remain unclear. This monocentric cohort study at Germany's largest neurosurgical clinic included 973 adults undergoing BrM resection (2010-2024), with histopathologically confirmed....

05/02/2026
🧠 Hydrocephalus in leptomeningeal disease – Case  : serial LPs → VP shuntMiddle-aged patient with advanced metastatic ca...
31/01/2026

🧠 Hydrocephalus in leptomeningeal disease – Case : serial LPs → VP shunt

Middle-aged patient with advanced metastatic carcinoma and known CNS involvement, now presenting with a classic hydrocephalus symptom triad in evolution: headache + nausea + recurrent vomiting. No focal deficit, fully awake.

🧾 Key facts

MRI (baseline): new ependymal / intraventricular lesion along the lateral ventricle → concern for impaired CSF dynamics

CSF: malignant cells → leptomeningeal disease confirmed

CT (follow-up): ventriculomegaly consistent with hydrocephalus

Clinically: pressure symptoms progressing despite supportive measures

🖼️ Serial imaging (right → middle → left)

Right: initial MRI

Middle: interval CT with hydrocephalus

Left: postop CT control with ventricular catheter in typical position after diversion

🧠 What we did (and why)
We used lumbar drainage pragmatically as a test and as a bridge:

Two therapeutic LPs

After the first, the patient had credible, but short-lived improvement

Symptoms recurred quickly, and ventricles remained enlarged on repeat CT

Larger-volume drainage again gave only temporary relief

At that point the trajectory was clear: this wasn’t going to be managed with repeated punctures. We moved to definitive CSF diversion.

✅ Plan / Outcome

VP shunt placed (postop control shown)

Parallel discussion with oncology: whether there’s a real, actionable plan for intrathecal therapy (and therefore whether an Ommaya makes sense upfront) vs keeping it simple with shunt alone.

❓ Questions for the group

Do you use serial LP response as a “shunt test” in suspected LMD-hydrocephalus, or do you go straight to diversion once CT confirms ventriculomegaly + symptoms?

In your practice, when do you add an Ommaya upfront (vs later, if intrathecal treatment becomes realistic)?

Any pearls on managing shunts in LMD patients (valve choice, overdrainage avoidance, infection risk mitigation)?

https://www.youtube.com/watch?v=cv21rU2g5vI
31/01/2026

https://www.youtube.com/watch?v=cv21rU2g5vI

The panelist and authors discuss the recently published Journal of Neuro-Oncology article: Laser interstitial thermal therapy (LITT) vs. bevacizumab for radi...

🧠 Neurooncology Case  #7: First Brain Metastasis in SCLCA 78-year-old female patient with a history of small cell lung c...
21/01/2026

🧠 Neurooncology Case #7: First Brain Metastasis in SCLC

A 78-year-old female patient with a history of small cell lung cancer (SCLC) was admitted for new-onset dysarthria and right-sided paresthesia. She was fully alert (GCS 15). Imaging revealed a right cerebellar lesion suggestive of a metastasis.

🧾 Medical History:

SCLC, diagnosed 04/2025 (T4N3M0, limited disease)

Prior treatment: concurrent chemoradiation therapy + maintenance atezolizumab (discontinued due to side effects)

Cardiovascular risk profile: Hypertension, history of NHL (2012), low-dose aspirin

🧠 Neurological Symptoms:

Dysarthria

Paresthesia on the right side

No ataxia or vomiting

No seizure activity

📷 Imaging:
MRI shows a contrast-enhancing cerebellar lesion with perifocal edema and mild mass effect — consistent with a first distant brain metastasis.

🩺 Management so far:

Dexamethasone initiated for edema control

Plan for inpatient transfer due to limited bed capacity

Pending further staging and MRI report

❓ Discussion points:

1️⃣ What’s your differential diagnosis in a patient with SCLC and a new cerebellar lesion?

2️⃣ How would you manage this patient acutely (e.g., Dexamethasone, seizure prophylaxis, imaging)?

3️⃣ What are the therapeutic options in first-time brain metastasis in SCLC?

-
-
-
-
-
-
-
-

-
-
-
-
-
-
-

✅ Case Notes:

In SCLC, brain metastases are common, but this is the first distant metastasis in a previously “limited disease” case.

This changes the staging and likely indicates transition to extensive disease.

Treatment may involve:

Stereotactic radiosurgery (SRS) or whole-brain radiotherapy (WBRT)

Discussion of systemic treatment adaptation (e.g., reintroduction or switch of checkpoint inhibitors)

Supportive care including steroids and symptom control

https://www.youtube.com/watch?v=FFZju5vcBi0Left-sided retrosigmoid craniotomy for the resection of a vestibular schwanno...
12/01/2026

https://www.youtube.com/watch?v=FFZju5vcBi0

Left-sided retrosigmoid craniotomy for the resection of a vestibular schwannoma

"Left-sided retrosigmoid craniotomy for the resection of a vestibular schwannoma"Peter S. Amenta, MD, and Jacques J. Morcos, MD, FRCS (Eng), FRCS (Ed)Univers...

🧠 Case  #6: Glioblastoma – Progression vs. Radiation Changes?A patient with a known IDH-wildtype glioblastoma (MGMT meth...
09/01/2026

🧠 Case #6: Glioblastoma – Progression vs. Radiation Changes?

A patient with a known IDH-wildtype glioblastoma (MGMT methylated), originally resected in 2018, presents with new neurological decline after years of regular follow-up.

🧾 Clinical background:

Location: Left precentral gyrus

Initial treatment: Resection + standard radiochemotherapy (STUPP)

Stable imaging for years

🔁 Current situation:

Progressive weakness in the right extremities

New seizures under dual antiepileptic therapy

MRI: Persistent contrast enhancement at resection cavity, stable in size but with increasing T2/FLAIR signal and perifocal edema

❓ Key clinical questions:

1️⃣ What’s your leading differential?

Treatment-related changes vs. true tumor progression?

2️⃣ Would you proceed with re-resection or advanced imaging?

3️⃣ Could systemic or anti-edema therapy (e.g., bevacizumab) be justified at this point?

✅ Case discussion:

🧠 Imaging features are not clearly progressive — stable contrast enhancement, no nodular recurrence
⚠️ Clinical worsening, however, suggests either pseudo-progression or subclinical progression

🔍 Planned approach:

FET-PET to clarify metabolic activity

If operable and metabolically active → re-resection

If suggestive of radiation necrosis → consider anti-VEGF therapy (e.g., Bevacizumab) for symptom and edema control

💬 How would you manage this patient?
Do you trust MRI alone, or do you rely on metabolic imaging like FET-PET?
Would you resect early or wait for progression?

Comment below ⬇️
📸 Selected MRI images to follow: before and after Avastin

🧠 Brain Metastases & Severe Edema – Case  #5: TNBC & Off-Label AvastinA middle-aged woman with metastatic triple-negativ...
09/01/2026

🧠 Brain Metastases & Severe Edema – Case #5: TNBC & Off-Label Avastin
A middle-aged woman with metastatic triple-negative breast cancer (TNBC) presents with neurological symptoms and radiological signs of intracranial progression.

🧾 Summary:
• Known systemic metastases (lung, bone, lymph nodes)
• History of stereotactic radiotherapy to multiple brain metastases
• Follow-up MRI: progression of intracranial disease, extensive vasogenic edema and midline shift
• Clinical signs: dizziness, fatigue, sensory changes, headaches
• No focal deficits, GCS 15

🧠 Management Decision:
Due to symptomatic intracranial mass effect and limited immediate radiotherapy options, a trial of off-label Bevacizumab (Avastin®) was recommended to reduce tumor-associated edema.

❓ Discussion Points:
1️⃣ Would you consider Bevacizumab in this case?
2️⃣ How do you manage severe perilesional edema post-radiation?
3️⃣ When is systemic therapy reconsidered in the context of intracranial progression?

Our approach see below.
-
-
-
-
-
-
-
-
-
-
-
-
-
-

✅ Strategy:
• Off-label Avastin initiated for edema control
• Corticosteroids for symptom relief
• Systemic therapy reassessment with oncology team
• Follow-up imaging planned after 4 treatment cycles

💬 What would your approach be in a similar scenario?

08/01/2026

Case report: a 23-year-old pregnant woman presented with seizures and chronic hepatitis B, with hyperintense lesions discovered in the left caudate nucleus on magnetic resonance imaging.

https://ja.ma/3Ld2coC

https://www.youtube.com/watch?v=hK7IWJ5fvlkCheck this webinar from the  AANS/CNS Section on Tumors - Intraoperative Fluo...
03/01/2026

https://www.youtube.com/watch?v=hK7IWJ5fvlk
Check this webinar from the
AANS/CNS Section on Tumors - Intraoperative Fluorescence-Guided Surgery and Photodynamic Therapy

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

Adresse

Hamburg-Wandsbek
22529

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Learning about Neurosurgery and Neurology erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram